1 / 16

Haiti/ Generality

HAITI COUNTRY REPORT Presented by: Moise Compere, MD.

marny-hogan
Download Presentation

Haiti/ Generality

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HAITI COUNTRY REPORTPresented by: Moise Compere, MD

  2. OUTLINE - GENERAL SITUATION AND STATISTICS- HAITI / A SUCCESS STORY- NATIONAL STRATEGIC PLAN - HIV RAPID TEST ALGORITHM - ARV REGIMENS USED IN HAITI - MONITORING AND EVALUATION - NATIONAL PLAN FOR SCALE UP - LABORATORY CAPACITIES- CHALLENGES

  3. Haiti/ Generality • Haitian Flag • Area : 27,750 square kilometers • Motto : L’union fait la force (Union make us strong) • Population : 10,250,000 inhabitants • Languages : Creole , French • Religions : Roman Catholic 80%, Protestant 16% Voodoo (African religion) 50%

  4. General situation and statistics Female population : 51.7% Male population : 48.3% Life expectancy ( Males) : 61 Years Life expectancy ( Females) : 64 Years Sources : 2012 EMMUS-V/ Haiti

  5. General situation and statistics continued ……. HIV prevalence : 2.2% ( NB: 6% in 1993 ) HIV PREVALENCE (Men) : 2.7% HIV PREVALENCE (women) : 1.7% ESTIMATED Number of people living with HIV : 120 000 Inhab Sources: 2012 EMMUS-V/ Haiti

  6. General situation and statistics cont. Number of people on ARVs : Number of people on Palliative care : Number of New infections : HIV prevalence for pregnant women : Percentage of HIV pregnant women on ARVS : ESTIMATED NUMBER OF ORPHANS FROM AIDS : 87,000 PREVALENCE of TB/HIV coinfection : 22 % Sources: 2012 EMMUS-V / UNICEF / UNGASS

  7. HAITI / A SUCCESS STORY People living with HIV/AIDS HIV/AIDS Deaths Source: CIA World Factbook

  8. National Strategic Plan 2008- 2012 Plan revolves around 5 major axes of intervention: • Leadership (Establishment of a system to guarantee the continuity of activities against HIV/AIDS) • Reduction of risk (Education, condoms, PMTCT ) • Reduction of impact (ARV, STI screening, Surveillance, Management PLWHA) • Human rights promotion and defense (PLWHA, stigmatization) • Monitoring, Evaluation and Research

  9. NATIONAL LAB HIV RAPID TEST ALGORITHM

  10. FIRST LINE ARV and ALTERNATIVE Préférentiels Alternatifs En cas d’intolérance au TDF ou d’insuffisance rénale, et d’anémie sévère En cas d’anémie ou co-infection VIH/TB En cas d’intolérance à EFV En cas d’intolérance *EFV ne doit pas être utilisé durant le premier trimestre de la grossesse Cas particulier du d4T : Les récentes études ont démontré les effets secondaires importants liés au d4T. En 2009, l’OMS conseille de cesser progressivement l’utilisation du d4T, en raison de ses effets secondaires toxiques. Toutefois, pour les patients préalablement placés sous cette molécule, avec une évolution clinique favorable, sans manifestation de toxicité ou d’intolérance, le prestataire jugera des risques encourus pour enlever ou poursuivre avec le d4T. À partir d’octobre 2010, le d4T ne sera utilisé chez les nouveaux patients qu’en présence des conditions figurant dans le tableau des régimes alternatifs. Manuel de Normes de Prise en Charge Clinique et Thérapeutique des Adultes et Adolescents Vivant avec le VIH, Ministère de la Santé publique et de la population, 2011

  11. SECOND LINE ARV Manuel de Normes de Prise en Charge Clinique et Thérapeutique des Adultes et Adolescents Vivant avec le VIH, Ministère de la Santé publique et de la population, 2011

  12. Monitoring and Evaluation

  13. National plan for Scale Up Scale-up support Global Fund for ATM (from March 2003) PEPFAR (from March 2004) 4 focus areas VCT Palliative Care PMTCT ART

  14. Laboratory Capacities • Elisa / Rapid Test / Ora-quick • CD4 testing capability: Pointcare, FACSCount and Coulter (Manual) • Viral Load Capability: PCR (EasyQ, EID) but limited • Viral resistance testing: Yes but limited • Other STI testing: Ex: Syphilis, HEPATITIS B,gonnorrhes • Other relevant Tests: p24 assay for infant diagnosis but limited

  15. Identify and reduce social causes associated with risk and vulnerability Reduce gender disparity Fight against stigmatisation Poverty Reduce the impact on households, communities and society Reach the national fixed targets in order to keep the financing from PEPFAR and Global Fund Challenges

  16. Thank you very much / Mèsi Anpil… Merci Beaucoup… • H Haitian resistance symbol

More Related